Single Subject Neratinib in Bladder Cancer

Trial Profile

Single Subject Neratinib in Bladder Cancer

Phase of Trial: Clinical Phase Unknown

Latest Information Update: 16 Mar 2017

At a glance

  • Drugs Neratinib (Primary)
  • Indications Bladder cancer
  • Focus Expanded access; Therapeutic Use
  • Most Recent Events

    • 01 Jul 2016 Status changed from active, no longer recruiting to completed.
    • 10 Oct 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top